TR201902737U5 - Mat Entegreli Taktik Sedye - Google Patents

Mat Entegreli Taktik Sedye Download PDF

Info

Publication number
TR201902737U5
TR201902737U5 TR2019/02737U TR201902737U TR201902737U5 TR 201902737 U5 TR201902737 U5 TR 201902737U5 TR 2019/02737 U TR2019/02737 U TR 2019/02737U TR 201902737 U TR201902737 U TR 201902737U TR 201902737 U5 TR201902737 U5 TR 201902737U5
Authority
TR
Turkey
Prior art keywords
stretcher
mat
base
tactical
matt
Prior art date
Application number
TR2019/02737U
Other languages
English (en)
Inventor
Aktaş Meli̇h
Aydin Yusuf
Original Assignee
Fora Grup Savunma Teknolojileri Ve Danismanlik Ticaret Ltd Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fora Grup Savunma Teknolojileri Ve Danismanlik Ticaret Ltd Sirketi filed Critical Fora Grup Savunma Teknolojileri Ve Danismanlik Ticaret Ltd Sirketi
Priority to TR2019/02737U priority Critical patent/TR201902737U5/tr
Publication of TR201902737U5 publication Critical patent/TR201902737U5/tr

Links

Landscapes

  • Invalid Beds And Related Equipment (AREA)

Abstract

Buluş, zor arazi şartlarında hasta ve yaralıların üzerinde taşındığı bir platform olan taktik sedyeye (1) mat (2) entegre edilerek, Taşıma kolonu cebinin (3) mat tabanı (2.1) üzerinde olduğu, taşıma kolonunun (4) da hem sedye tabanından (1.1), hem de mat tabanından (2.1) geçirilerek yaralı taşıma işlemine ilave yardım sağlandığı, Yaralı kişi ile sedye tabanı (1.1) arasında yastıklama yapıldığı, yaralı kişi vücudu ile sedye tabanı (1.1) arasında yalıtım sağlandığı, Mat entegreli taktik sedye olup, Taktik sedye (1), mat (2), taşıma kolonu cebi (3) ve taşıma kolonuna (4) sahip olması ile ilgilidir.
TR2019/02737U 2019-02-25 2019-02-25 Mat Entegreli Taktik Sedye TR201902737U5 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2019/02737U TR201902737U5 (tr) 2019-02-25 2019-02-25 Mat Entegreli Taktik Sedye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/02737U TR201902737U5 (tr) 2019-02-25 2019-02-25 Mat Entegreli Taktik Sedye

Publications (1)

Publication Number Publication Date
TR201902737U5 true TR201902737U5 (tr) 2019-03-21

Family

ID=67981589

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02737U TR201902737U5 (tr) 2019-02-25 2019-02-25 Mat Entegreli Taktik Sedye

Country Status (1)

Country Link
TR (1) TR201902737U5 (tr)

Similar Documents

Publication Publication Date Title
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
DE602005023488D1 (de) Tumorassoziierte antigenprofile in der krebsdiagnostik und immuntherapie
WO2018187227A8 (en) Methods for treating cancer using ps-targeting antibodies with immuno-oncology agents
CY1107773T1 (el) Τυποποιησεις που περιεχουν εκτεïνασκιδινη και δισακχαριτη
ATE311910T1 (de) Identification from ampoule
WO2007006043A3 (en) Medical devices with machined layers for controlled communication with underlying regions
NL300418I1 (nl) Gebruik van trifunctionele bispecifieke en trispecifieke antilichamen voor de behandeling van maligne ascitis
BR112012008161B8 (pt) dispositivo que pode ser usado no corpo do usuário para prover vácuo para usos clínicos
GT200600046A (es) Terapia de combinacion
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
ATE532469T1 (de) In eine menschliche oder tierische knochenstruktur einführbares konnektionsmittel und zugehöriges lokalisationssystem
DE50206252D1 (de) Patientenlagerungs- und transportsystem
AR045870A1 (es) Terapia de combinacion para la infeccion de virus de hepatitis c
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
WO2019234241A8 (en) ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENT
EA200801853A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
ATE445404T1 (de) Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose
CY1117839T1 (el) Γονιδιο τομ34 σχετιζομενο με καρκινο του παχεος εντερου
CY1123696T1 (el) Φαρμακο για τη θεραπεια των μολυνσεων του διαβητικου ποδιου
TR201902737U5 (tr) Mat Entegreli Taktik Sedye
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
BR112019001130A2 (pt) uso de lactama e composição farmacêutica
BR112021016923A2 (pt) Métodos para tratar um paciente com câncer hematológico, métodos para tratar um paciente com mm recidivante ou refratário, métodos para tratar um paciente tendo um lnh recidivante ou refratário e kits
ATE520412T1 (de) Therapien für chronisch inflammatorische demyelinisierende polyradikuoneuropathie mit interferon-beta
Roschewski et al. Are We Too Reliant on Radiation Therapy for Children with Hodgkin's Lymphoma?